Table 5. Univariate and multivariate analyses for predicting cause-specific survival in bladder cancer patients treated with chemoradiotherapy.

	(a) Univariate analysisa				(b) Multivariate analysisb
	Variable	Category	P-value		Risk ratio (95% CI) P-value
	D1S 171	Balance or imbalance	0.2588	NS	NS
Microsatellite markers	TP73		0.0013		3382(not calculated) 0.0002
	D1S243		0.0482		NS
	D1S244		0.8444	NS	NS
	RIZ		0.6178	NS	NS
	D1S507		0.2756	NS	NS
	D1S247		0.9640	NS	NS
	ABR		0.2051	NS	NS
	D17S1574		0.1859	NS	NS
	YNZ22		0.3886	NS	NS
	D17S1566		0.5149	NS	NS
	ENO3		0.7176	NS	NS
	TP53		0.4529	NS	NS
	D17S520		0.2632	NS	NS
Clinical parameters	Age	⩽68 years or >68 years	0.6652	NS	NS
	PS	0 or >0	0.0113		2.911(1.31–12.38)0.0047
	Tumour grade	G2 or G3	1.0000	NS	NS
	Tumour stage	Tl or T2 or T3 & T4	0.5989	NS	NS
	Recurrence	Yes or No	0.0027		3.467(1.50–14.90)0.0017
	Response	CR or non-CR	0.4916	NS	NS
	CDDP doses	⩽220 mg or >220 mg	0.3634	NS	NS
	Radiation doses	⩽32.4 Gy or >32.4 Gy	0.0486		1.655(1.007–2.935) 0.0468

^aUsed Log-rank test.

^bUsed the Cox proportional hazard test.

CDDP=cis-platinum; CR=clinical response; NS=not significant.